Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amorphous salt of a macrocyclic inhibitor of HCV

Amorphous salt of a macrocyclic inhibitor of HCV

US Patent 9321758 · Granted Apr 26, 2016

Estimated economic value: $49,334,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Toll-like receptor agonists for use in the treatment of hepatitis b2025
Aqueous suspensions of TMC2782022
Prodrug modulators of the cystic fibrosis transmembrane conductance regulator pr2022
Macrocyclic inhibitors of hepatitis C virus2018
Macrocyclic inhibitors of hepatitis C virus2017
Macrocyclic inhibitors of hepatitis C virus2016
Macrocyclic inhibitors of hepatitis C virus2016
Pharmaceutical compositions comprising a basic drug compound, a surfactant, and 2015
Macrocyclic inhibitors of hepatitis C virus2015
Powders for reconstitution2014
Macrocyclic inhibitors of hepatitis C virus2014
Macrocyclic inhibitors of hepatitis C virus2014